We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-6.42%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$3.29B
AUM Growth
+$73M
Cap. Flow
+$288M
Cap. Flow %
8.77%
Top 10 Hldgs %
33.54%
Holding
352
New
136
Increased
52
Reduced
76
Closed
78

Top Buys

Rank Stock Value
1
LIVN icon
LivaNova
LIVN
+$42.5M
2
MAPS
WM TECHNOLOGY INC A
MAPS
+$23.3M
3
SEER icon
Seer Inc
SEER
+$20.8M
4
GKOS icon
Glaukos
GKOS
+$17.9M
5
COO icon
Cooper Companies
COO
+$17.1M

Top Sells

Rank Stock Value
1
INOV
Inovalon Holdings, Inc. Class A Common Stock
INOV
+$60.7M
2
NTLA icon
Intellia Therapeutics
NTLA
+$26.2M
3
ORGO icon
Organogenesis Holdings
ORGO
+$19.9M
4
LLY icon
Eli Lilly
LLY
+$15.1M
5
CMIIU
CM Life Sciences II Inc. Unit
CMIIU
+$14.1M

Sector Composition

Rank Sector Weight
1 Healthcare 33.25%
2 Consumer Staples 0.8%
3 Technology 0.71%
4 Industrials 0.71%
5 Materials 0.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NAUT icon
226
Nautilus Biotechnolgy
NAUT
$114M
$911K 0.03%
148,300
-58,779
-28% -$468K
NGM
227
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$911K 0.03%
+43,317
New +$954K
CCCC icon
228
C4 Therapeutics
CCCC
$480M
$894K 0.03%
+20,000
New +$856K
GNLN icon
229
Greenlane Holdings
GNLN
$1.19M
– –
0
– –
PSTX
230
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$834K 0.03%
114,343
-28,777
-20% -$247K
CSII
231
PUT
DELISTED
Cardiovascular Systems, Inc.
CSII
$821K 0.03%
+25,000
New +$933K
SPKBU
232
DELISTED
Silver Spike Acquisition Corp II Units
SPKBU
$777K 0.02%
77,505
– –
XENE icon
233
Xenon Pharmaceuticals
XENE
$6.31B
$764K 0.02%
+50,000
New +$869K
XENE icon
234
PUT
Xenon Pharmaceuticals
XENE
$6.31B
$764K 0.02%
+50,000
New +$869K
TBPH icon
235
CALL
Theravance Biopharma
TBPH
$878M
$740K 0.02%
+100,000
New +$1.12M
TBPH icon
236
Theravance Biopharma
TBPH
$878M
$740K 0.02%
100,000
+51,234
+105% +$573K
BLU
237
PUT
DELISTED
BELLUS Health Inc.
BLU
$720K 0.02%
+117,300
New +$445K
SLGCW
238
DELISTED
SomaLogic, Inc. Warrant
SLGCW
$716K 0.02%
+207,527
New +$639K
CCXI
239
CALL
DELISTED
ChemoCentryx, Inc.
CCXI
$694K 0.02%
+40,600
New +$633K
UPC icon
240
Universe Pharmaceuticals Inc
UPC
$3.93M
$662K 0.02%
+74
New +$680K
KRYS icon
241
PUT
Krystal Biotech
KRYS
$9.85B
$642K 0.02%
12,300
-200
-2% -$11.8K
RPTX
242
DELISTED
Repare Therapeutics
RPTX
$581K 0.02%
22,143
-29,128
-57% -$941K
TRAW icon
243
Traws Pharma
TRAW
$8.12M
$575K 0.02%
+6,000
New +$773K
BGMS
244
Bio Green Med Solution Inc
BGMS
$5.1M
$554K 0.02%
29
-15
-34% -$288K
DFTX
245
CALL
Definium Therapeutics
DFTX
$5.68B
$518K 0.02%
+14,813
New +$640K
ISEE
246
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$516K 0.02%
31,765
-16,300
-34% -$177K
IPHA
247
Innate Pharma
IPHA
$232M
$509K 0.02%
+82,509
New +$355K
CTMX icon
248
CytomX Therapeutics
CTMX
$760M
$506K 0.02%
99,371
-1,470
-1% -$7.87K
DCPH
249
PUT
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$462K 0.01%
+13,600
New +$434K
KDMN
250
DELISTED
Kadmon Holdings, Inc.
KDMN
$456K 0.01%
+52,300
New +$298K
8 9
10
11 12

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q3 2021 Portfolio in Review

As of Q3 2021, Pura Vida Investments held 352 positions worth $3.29B, up 2.3% from $3.21B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Pura Vida Investments deployed $288M of net new capital in Q3 2021, opening 136 new positions and adding to 52 existing holdings. Its largest new stake was WM TECHNOLOGY INC A: 1,612,498 shares worth $23.4M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 35% a quarter earlier, followed by Consumer Staples and Technology.

On the sell side, the largest reduction was Intellia Therapeutics, an estimated $26.2M trimmed.

  • Pura Vida Investments's largest Q3 2021 buy was WM TECHNOLOGY INC A: 1,612,498 shares worth $23.4M.
  • Pura Vida Investments added most to LivaNova in Q3 2021, an estimated $42.5M increase.
  • Pura Vida Investments's biggest Q3 2021 reduction was Intellia Therapeutics, cutting an estimated $26.2M.
  • Pura Vida Investments fully exited Inovalon Holdings, Inc. Class A Common Stock in Q3 2021, selling an estimated $60.7M.
  • Pura Vida Investments's ten largest holdings make up 34% of its $3.29B portfolio in Q3 2021.
  • Pura Vida Investments opened 136 new positions and closed 78 in Q3 2021.
  • Pura Vida Investments's portfolio value rose 2.3% quarter-over-quarter to $3.29B.

Based on Pura Vida Investments's 13F filing for Q3 2021, filed 15 Nov 2021.